Date: August 19, 2010
Summary:
In an official company news release, Stem Cells, Inc., a biotechnology company in the field of stem cell research, announced the publication of new preclinical data demonstrating that human neural stem cells restore lost motor function in mice with chronic spinal cord injury:
StemCells, Inc. announced today the publication of new preclinical data demonstrating that the Company’s proprietary human neural stem cells restore lost motor function in mice with chronic spinal cord injury. This is the first published study to show that human neural stem cells can restore mobility even when administered at time points beyond the acute phase of trauma, suggesting the prospect of treating a much broader population of injured patients than previously demonstrated. This groundbreaking study, entitled “Human Neural Stem Cells Differentiate and Promote Locomotor Recovery in an Early Chronic Spinal Cord Injury NOD-scid Mouse Model,” was led by Dr. Aileen Anderson of the Sue and Bill Gross Stem Cell Research Center at the University of California, Irvine (UCI). The paper was published yesterday in the international peer-reviewed journal PLoS ONE.
A news story about this study was published by Reuters yesterday.
